← Open Payments lookup

CAROLYN CANTERBURY: Open Payments

NPI 1942510102 · MONTGOMERY CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$735 in 39 payments from 13 companies in 2025. Trend: 2023 $182 · 2024 $535 · 2025 $735

Food & beverage: $735
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$182
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$120
Alkermes, Inc.5$95
Otsuka America Pharmaceutical, Inc.3$73
Vanda Pharmaceuticals Inc.2$52
Aimmune Therapeutics, Inc.2$40
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
Teva Pharmaceuticals USA, Inc.2$34
Collegium Pharmaceutical, Inc.2$31
Takeda Pharmaceuticals U.S.A., Inc.1$20

Products named: INGREZZA, CAPLYTA, ARISTADA, REXULTI, FANAPT, ZENPEP, JARDIANCE, UZEDY.

Industry payments across MO — which companies pay providers there.